Skip to Main Content

An official website of the United States government

Government Funding Lapse

Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit  cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at OPM.gov.

About this Publication
Title
Predicting non-melanoma skin cancer via a multi-parameterized artificial neural network.
Pubmed ID
29374196 (View this publication on the PubMed website)
Digital Object Identifier
Publication
Sci Rep. 2018 Jan 26; Volume 8 (Issue 1): Pages 1701
Authors
Roffman D, Hart G, Girardi M, Ko CJ, Deng J
Affiliations
  • Department of Therapeutic Radiology, School of Medicine, Yale University, New Haven, USA.
  • Department of Dermatology, School of Medicine, Yale University, New Haven, USA.
  • Department of Therapeutic Radiology, School of Medicine, Yale University, New Haven, USA. jun.deng@yale.edu.
Abstract

Ultraviolet radiation (UVR) exposure and family history are major associated risk factors for the development of non-melanoma skin cancer (NMSC). The objective of this study was to develop and validate a multi-parameterized artificial neural network based on available personal health information for early detection of NMSC with high sensitivity and specificity, even in the absence of known UVR exposure and family history. The 1997-2015 NHIS adult survey data used to train and validate our neural network (NN) comprised of 2,056 NMSC and 460,574 non-cancer cases. We extracted 13 parameters for our NN: gender, age, BMI, diabetic status, smoking status, emphysema, asthma, race, Hispanic ethnicity, hypertension, heart diseases, vigorous exercise habits, and history of stroke. This study yielded an area under the ROC curve of 0.81 and 0.81 for training and validation, respectively. Our results (training sensitivity 88.5% and specificity 62.2%, validation sensitivity 86.2% and specificity 62.7%) were comparable to a previous study of basal and squamous cell carcinoma prediction that also included UVR exposure and family history information. These results indicate that our NN is robust enough to make predictions, suggesting that we have identified novel associations and potential predictive parameters of NMSC.

Related CDAS Studies
Related CDAS Projects